Choroid is principally that portion of eye that lies in between the retina and the sclera. It is said that this particular region of eye comprises of blood vessels that constantly offers nutrients to the retinal part of our eye. Choroidal Neovascularization (CNV) Market size on the basis of methods of diagnosis spans Fluorescein Angiography (FA), Indocyanine Green (ICG) angiography, and spectral domain Optical Coherence Tomography (OCT).
Choroidal
Neovascularization (CNV) is an ailment, that is distinguished by the formation
of new blood vessels that evolve either because of the existence of Vascular
Endothelial Growth Factors or because of Age-related Macular Degeneration
(AMD). It has been noted that this particular disease is quite prominently
occurring in the population with flaws in the inmost stratum of the choroid
known as Bruch's membrane. It is linked with the production of new blood
vessels in the choroidal layer of eye.
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/choroidal-neovascularization-cnv-market/request-sample
These blood vessels may
suddenly break into the retina and give rise to disruption as well as sight
loss/vision loss. The key symptoms of this disorder may encompass loss of
vision, metamorphopsia, paracentral or central scotoma, and apparent change in
image size. This disease frequently takes place among the aged group of
population and among people who are suffering from severe myopia. Among all,
Fluorescein Angiography (FA) is the most frequently employed diagnosis
technique.
And now days, it has been
observed that the method of spectral domain OCT has occupied the position of
FA, the reason being its attached benefits and highly accurate treatment
provided by it. The studies show that CNV very often originate from posterior
pole lesions and therefore it becomes quite difficult to spot and identify.
Thus, it is very essential to take up an accurate and precise diagnosis in
order to get relief from CNV. Researchers have identified a wide range of
diagnosis methods of CNV along with various treatments.
As far the treatments are
concerned, the prominent ones include angiogenesis inhibitors injection,
photodynamic therapy, laser photocoagulation, low dose radiation therapy as
well as surgery. Among all these mentioned treatments, it is said that
angiogenesis inhibitor injection is the most traditional technique to
administer the development of blood vessels by decreasing the area of fluid
that is just below the retinal pigment epithelium.
The prominent factor that
is playing a major part in raising the Choroidal Neovascularization (CNV)
market share include high rate of increment in CNV affected patients owing to
augmented aged population. In addition, the concerned government authorities
and heath care departments across the globe are taking up various initiatives
for raising awareness among the masses regarding the disease. Plus, they are
offering appropriate diagnosis and treatments at reasonable prices.
This is in turn assisting
in compelling the overall growth of Choroidal Neovascularization (CNV) market.
The only factors that are turning as major hurdles in the market growth include
high lack of awareness among masses especially in the African and Asian regions
regarding various kinds of eye diseases and soaring cost attached with its
treatment.
Additionally,
inaccessibility of better healthcare infrastructure, enhanced facilities and
high grade care of patients are still standing in the mid-way as major challenges
in the market growth. Choroidal Neovascularization (CNV) Market size on the
basis of geography spans North America, Europe, Asia-Pacific, South America,
and Middle East and Africa. As far as the geography is concerned, Asia Pacific
is currently leading the market and it is anticipated that it will rise with a
robust CAGR in the next couple of years particularly in the countries like
China, and India.
On the other hand, North
America is also emerging in the Choroidal Neovascularization (CNV) market owing
to the large number of aged population present in the particular region. It is
noted that the region is highly affected by this disease. The key players
operating in the Choroidal Neovascularization (CNV) market include Bayer AG,
Resolvyx Pharmaceuticals Inc, F. Hoffmann-La Roche Ltd, Valeant Pharmaceuticals
International Inc., and Chengdu Kanghong Biotech Co. Ltd.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment